Michael T. McCurdy

Dr. Michael T. McCurdy

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2022 in Nature
Verified
Journal Article
Open access
PDF file
SSSydney R. Stein
Sydney R. Stein
SRSabrina C. Ramelli
Sabrina C. Ramelli
AGAlison Grazioli
Alison Grazioli
Joon-Yong ChungJoon-Yong Chung
Joon-Yong Chung
MSManmeet Singh
Manmeet Singh
DCDaniel S. Chertow
Daniel S. Chertow
Coronavirus disease 2019 (COVID-19) is known to cause multi-organ dysfunction1,2,3 during acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with some patients experiencing prolonged symptoms, termed post-acute sequelae of SARS-CoV-2 (refs. 4,5). However, the burden of infection outside the respiratory tract and time to viral clearance are not well characterized, particularly in the brain3,6,7,8,9,10,11,12,13,14. Here we carried out complete autopsies on 44 patients who died with COVID-19, with extensive sampling of the central nervous system in 11 of these patients, to map and quantify the distribution, replication and cell-type specificity of SARS-CoV-2 across the human body, including the brain, from acute infection to more than seven months following symptom onset. We show that SARS-CoV-2 is widely distributed, predominantly among patients who died with severe COVID-19, and that virus replication is present in multiple respiratory and non-respiratory tissues, including the brain, early in infection. Further, we detected persistent SARS-CoV-2 RNA in multiple anatomic sites, including throughout the brain, as late as 230 days following symptom onset in one case. Despite extensive distribution of SARS-CoV-2 RNA throughout the body, we observed little evidence of inflammation or direct viral cytopathology outside the respiratory tract. Our data indicate that in some patients SARS-CoV-2 can cause systemic infection and persist in the body for months.

25 March 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
NHNi Huang
Ni Huang
PPPaola Pérez
Paola Pérez
TKTakafumi Kato
Takafumi Kato
YMYu Mikami
Yu Mikami
KOKenichi Okuda
Kenichi Okuda
ISInês Sequeira
Inês Sequeira

4 September 2019 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
NBNoel Britton
Noel Britton
MMMichael A. Miller
Michael A. Miller
SSSami Safadi
Sami Safadi
ASAriel Siegel
Ariel Siegel
ALAndrea R. Levine
Andrea R. Levine
MMMichael T. McCurdy
Michael T. McCurdy
Background: Telemedicine, or healthcare delivery from a distance, has evolved over the past 50 years and helped alter health care delivery to patients around the globe. Its integration into numerous domains has permitted high quality care that transcends obstacles of geographic distance, lack of access to health care providers, and cost. Ultrasound is an effective diagnostic tool and its application within telemedicine (“tele-ultrasound”) has advanced substantially in recent years, particularly in high-income settings. However, the utility of tele-ultrasound in resource-limited settings is less firmly established. Objective: To determine whether remote tele-ultrasound is a feasible, accurate, and care-altering imaging tool in resource-limited settings. Data Sources: PubMed, MEDLINE, and Embase. Study Eligibility Criteria: Twelve original articles met the following eligibility criteria: full manuscript available, written in English, including a direct patient-care intervention, performed in a resource-limited setting, images sent to a remote expert reader for interpretation and feedback, contained objective data on the impact of tele-ultrasound. Study Appraisal and Synthesis Methods: Abstracts were independently screened by two authors against inclusion criteria for full-text review. Any discrepancies were settled by a senior author. Data was extracted from each study using a modified Cochrane Consumers and Communication Review Group's data extraction template. Study bias was evaluated using the ROBINS-I tool. Results: The study results reflect the diverse applications of tele-ultrasound in low-resource settings. Africa was the most common study location. The specialties of cardiology and obstetrics comprised most studies. Two studies primarily relied on smartphones for image recording and transmission. Real-time, rather than asynchronous, tele-ultrasound image interpretation occurred in five of the 12 studies. The most common outcome measures were image quality, telemedicine system requirements, diagnostic accuracy, and changes in clinical management. Limitations: The studies included were of poor quality with a dearth of randomized control trials and with significant between study heterogeneity which resulted in incomplete data and made cross study comparison difficult. Conclusions and Implications of Key Findings: Low-quality evidence suggests that ultrasound images acquired in resource-limited settings and transmitted using a telemedical platform to an expert interpreter are of satisfactory quality and value for clinical diagnosis and management.

20 December 2021 in Research Square
Verified
Preprint
Open access
PDF file
DCDaniel S. Chertow
Daniel S. Chertow
SSSydney Stein
Sydney Stein
SRSabrina Ramelli
Sabrina Ramelli
AGAlison Grazioli
Alison Grazioli
Joon-Yong ChungJoon-Yong Chung
Joon-Yong Chung
DKDavid Kleiner
David Kleiner
COVID-19 is known to cause multi-organ dysfunction1-3 in acute infection, with prolonged symptoms experienced by some patients, termed Post-Acute Sequelae of SARS-CoV-2 (PASC)4-5. However, the burden of infection outside the respiratory tract and time to viral clearance is not well characterized, particularly in the brain3,6-14. We performed complete autopsies on 44 patients with COVID-19 to map and quantify SARS-CoV-2 distribution, replication, and cell-type specificity across the human body, including brain, from acute infection through over seven months following symptom onset. We show that SARS-CoV-2 is widely distributed, even among patients who died with asymptomatic to mild COVID-19, and that virus replication is present in multiple extrapulmonary tissues early in infection. Further, we detected SARS-CoV-2 RNA in multiple anatomic sites, including regions throughout the brain, for up to 230 days following symptom onset. Despite extensive distribution of SARS-CoV-2 in the body, we observed a paucity of inflammation or direct viral cytopathology outside of the lungs. Our data prove that SARS-CoV-2 causes systemic infection and can persist in the body for months.

1 May 2014 in Emergency Medicine Clinics of North America
Verified
Journal Article
Closed access
WCWan-Tsu W. Chang
Wan-Tsu W. Chang
BRBethany Radin
Bethany Radin
MMMichael T. McCurdy
Michael T. McCurdy

1 October 2015 in Journal of Critical Care
Verified
Journal Article
Closed access
ALAndrea R. Levine
Andrea R. Levine
MMMichael T. McCurdy
Michael T. McCurdy
MZMarc T. Zubrow
Marc T. Zubrow
APAlfred Papali
Alfred Papali
HMHaney A. Mallemat
Haney A. Mallemat
AVAvelino C. Verceles
Avelino C. Verceles